Bradley Alford - Perrigo Company Independent Director

<div class='circular--portrait' style='background:#0D8ECF;color: white;font-size:3em;padding-top: 25px;;'>PRG</div>
PRGO -- USA Stock  

Last Earning Anouncement Date: December 31, 2015  

  Director
Mr. Bradley A. Alford serves as Independent Director of the Company. Mr. Alford joined Advent International Corporationrationration, a global private equity firm, in 2014 as an Industry Advisor and moved to Operating Partner in March of 2016. From 2006 to 2013, Mr. Alford was Chairman and Chief Executive Officer of Nestl USA. Mr. Alford also served as CEO and President of Nestl Brands Company. He currently serves as a director of Avery Dennison Corporationrationration since April 2010 and previously served as a director of Conagra Brands, Inc. from July 2015 to September 2018. Throughout his career, Mr. Alford was focused on developing brands, initiatives to improve processes and facilitate best practices across an organization.
Age: 61  Director Since 2017      
353 1 709 4000  http://www.perrigo.com

Bradley Alford Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of 2.19 % which means that it generated profit of $2.19 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of 4.32 % meaning that it created $4.32 on every $100 dollars invested by stockholders.
The company currently holds 3.5 B in liabilities with Debt to Equity (D/E) ratio of 60.7 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Perrigo Company has Current Ratio of 2.03 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Showing few of many executives

DIRECTOR Since

Huda ZoghbiRegeneron Pharmaceuticals
2016
Elaine UllianVertex Pharmaceuticals Incorpor
2011
Sangeeta BhatiaVertex Pharmaceuticals Incorpor
2015
Fei WangOrigin Agritech Limited
2019
William DoyleZoetis
2015
Alfred GilmanRegeneron Pharmaceuticals
1990
David AltshulerVertex Pharmaceuticals Incorpor
2015
Leo PuriDr Reddys Laboratories Ltd
2018
Joseph GoldsteinRegeneron Pharmaceuticals
1991
Paul BisaroZoetis
2015
Yuchun LeeVertex Pharmaceuticals Incorpor
2012
Alan GarberVertex Pharmaceuticals Incorpor
2017
Frank DAmelioZoetis
2016
Louise ParentZoetis
2013
Bruce SachsVertex Pharmaceuticals Incorpor
2017
Ashok GangulyDr Reddys Laboratories Ltd
2009
James KangOrigin Agritech Limited
2010
Marc TessierLavigneRegeneron Pharmaceuticals
2011
Willie ReedZoetis
2014
Gregory NordenZoetis
2013
J MoreauDr Reddys Laboratories Ltd
2007

Entity Summary

Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland. Perrigo Company operates under Drug ManufacturersSpecialty Generic classification in USA and is traded on BATS Exchange. It employs 10600 people.Perrigo Company Plc (PRGO) is traded on BATS Exchange in USA and employs 10,600 people.

Perrigo Company Leadership Team

John Hendrickson, President
Gary Cohen, Independent Director
Arthur Shannon, IR Contact Officer
Ronald Winowiecki, Acting CFO
Svend Andersen, Executive Vice President and President - Consumer Healthcare International
Judy Brown, CFO and Executive VP
Laurie Brlas, Independent Director
Donal OConnor, Independent Director
James Michaud, Chief Human Resource Officer, Executive Vice President
Louis Yu, Executive Vice President - Global Quality
John Wesolowski, Executive Vice President and Presidentident - RX
Theodore Samuelsto, Independent Director
Scott Jamison, Executive Vice President General Manager - Nutritionals
Ellen Hoffing, Independent Director
Marc Coucke, Executive Vice President General Manager - Omega Pharma Business
Adriana Karaboutis, Independent Director
Michael Jandernoa, Independent Director
Paul Weninger, Executive Vice President - Global Quality Operations
Thomas Farrington, Senior Vice President CIO
Herman Morris, Independent Director
Jeffrey Needham, Executive Vice President General Manager - Consumer Healthcare
Todd Kingma, Executive VP, General Counsel and Secretary
Rolf Classon, Independent Director
Raymond Silcock, CFO
Shlomo Yanai, Independent Director Nominee
Jatin Shah, Senior Vice President Chief Scientific Officer
Michael Stewart, Senior Vice President - Global Human Resources
Jeffrey Kindler, Independent Director
Jacqualyn Fouse, Independent Director
Grainne Quinn, Executive Vice President Chief Medical Officer
Theodore Samuels, Independent Director
Geoffrey Parker, Independent Director
Murray Kessler, President CEO, Director
Sharon Kochan, Executive VP and General Manager of International
Gary Kunkle, Lead Independent Director
Joseph Papa, Chairman and CEO
Marry Brlas, Independent Chairman of the Board
Bradley Alford, Independent Director
Jeffrey Smith, Independent Director
Bradley Joseph, IR Contact Officer
James Dillard, Executive Vice President Chief Scientific Officer
Douglas Boothe, Executive Vice President General Manager - Rx Pharmaceuticals
Ronald Janish, Executive Vice President - Global Operations and Supply Chain
Uwe Rohrhoff, President CEO, Director

Stock Performance Indicators

Current Sentiment - PRGO

Perrigo Company Investor Sentiment

Most of Macroaxis users are at this time bullish on Perrigo Company Plc. What is your perspective on investing in Perrigo Company Plc? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Currently Active Assets on Macroaxis

USRT   
Purchased few shares of
a day ago
Traded for 55.68
IJR   
Purchased few shares of
a day ago
Traded for 85.37
IJH   
Purchased one share of
a day ago
Traded for 209.15
IVV   
Purchased one share of
a day ago
Traded for 333.5
IDEV   
Purchased few shares of
a day ago
Traded for 59.01
Please also check Your Equity Center. Please also try Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.